Status of incremental costs of first-line treatment recommended in Japanese clinical guidelines for metastatic breast cancer patients.
Iwatani T, Sasaki K, Machida R, Shien T, Hara F, Fujisawa T, Takano Y, Kobayashi Y, Saimura M, Koizumi K, Terada M, Sasada S, Saito K, Sumiyoshi M, Iwata H.
Iwatani T, et al. Among authors: sasaki k.
Jpn J Clin Oncol. 2024 Oct 3;54(10):1093-1099. doi: 10.1093/jjco/hyae109.
Jpn J Clin Oncol. 2024.
PMID: 39178176